Ionis Pharmaceuticals Inc
XMUN:ISI
Ionis Pharmaceuticals Inc
XMUN:ISI
Price:
63.8
EUR
0.31%
Market Closed
Market Cap:
€4.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
|
E
|
Equinor ASA
XMUN:DNQ
|
NO |
|
Sinotruk Hong Kong Ltd
HKEX:3808
|
CN |
|
Power Corporation of Canada
TSX:POW
|
CA |
|
B
|
Budweiser Brewing Company APAC Ltd
F:4BB
|
HK |
|
U
|
UFP Technologies Inc
XMUN:UFP
|
US |
|
Ggx Gold Corp
F:3SR
|
CA |
|
Z
|
Zalando SE
XMUN:ZAL
|
DE |
|
A
|
ABx Group Ltd
ASX:ABX
|
AU |
|
P
|
Pennon Group PLC
OTC:PEGRY
|
UK |
|
Sogeclair SA
LSE:0OQ2
|
FR |
|
D
|
Danaher Corp
LSE:0R2B
|
US |
Wall St Price Targets
ISI Price Targets Summary
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Wall Street analysts forecast ISI stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for ISI is 85.64 EUR with a low forecast of 39.64 EUR and a high forecast of 116.46 EUR.
Lowest Forecast
Price Target
39.64
EUR
38% Downside
Average Forecast
Price Target
85.64
EUR
34% Upside
Highest Forecast
Price Target
116.46
EUR
83% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ISI's stock price target?
Price Target
85.64
EUR
85.64
EUR
According to Wall Street analysts, the average 1-year price target for ISI is 85.64 EUR with a low forecast of 39.64 EUR and a high forecast of 116.46 EUR.
What is the Revenue forecast for Ionis Pharmaceuticals Inc?
Projected CAGR
25%
25%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 25%.
